|
Q3 FY2026
As of Jul 31, 2026
|
Q2 FY2026
As of Apr 30, 2026
|
Q1 FY2026
As of Jan 31, 2026
|
Q4 FY2025
As of Oct 31, 2025
|
Q3 FY2025
As of Jul 31, 2025
|
Q2 FY2025
As of Apr 30, 2025
|
Q1 FY2025
As of Jan 31, 2025
|
Q4 FY2024
As of Oct 31, 2024
|
Q3 FY2024
As of Jul 31, 2024
|
Q2 FY2024
As of Apr 30, 2024
|
Q1 FY2024
As of Jan 31, 2024
|
Q4 FY2023
As of Oct 31, 2023
|
Q3 FY2023
As of Jul 31, 2023
|
Q2 FY2023
As of Apr 30, 2023
|
Q1 FY2023
As of Jan 31, 2023
|
Q4 FY2022
As of Oct 31, 2022
|
Q3 FY2022
As of Jul 31, 2022
|
Q2 FY2022
As of Apr 30, 2022
|
Q1 FY2022
As of Jan 31, 2022
|
Q4 FY2021
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Other receivable - related party - short term | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Inventory deposit – related party | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Notes receivable, net | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other receivable - related party - net of current portion | ||||||||||||||||||||
| Right of use asset - operating lease | ||||||||||||||||||||
| Equity investment | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable - related party | ||||||||||||||||||||
| Loans payable, net | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Customer refund due | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Operating lease obligation - short term | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease obligation, net of current portion | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Commitments and Contingencies (Note 10) | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Common stock ($.001 par value, 1,000,000,000 shares authorized, 19,535,402 and 11,593,402 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
